- Report
- September 2026
- 186 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,077GBP
- Report
- September 2026
- 188 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,077GBP
- Report
- September 2026
- 194 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,077GBP
- Report
- September 2026
- 195 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,077GBP
- Report
- September 2026
- 279 Pages
Global
From €5316EUR$5,850USD£4,569GBP
- Report
- February 2026
- 250 Pages
Global
From €4080EUR$4,490USD£3,507GBP
- Report
- February 2026
- 250 Pages
Global
From €4080EUR$4,490USD£3,507GBP
- Report
- February 2026
- 250 Pages
Global
From €4080EUR$4,490USD£3,507GBP
- Report
- February 2026
- 250 Pages
Global
From €4080EUR$4,490USD£3,507GBP
- Report
- February 2026
- 250 Pages
Global
From €4080EUR$4,490USD£3,507GBP
- Report
- May 2026
- 185 Pages
Global
From €4089EUR$4,500USD£3,515GBP
- Report
- July 2026
- 224 Pages
Global
From €7260EUR$7,990USD£6,241GBP
- Report
- July 2026
- 244 Pages
Global
From €7260EUR$7,990USD£6,241GBP
- Report
- August 2026
- 110 Pages
Global
From €4316EUR$4,750USD£3,710GBP
- Report
- December 2025
- 150 Pages
Global
From €4407EUR$4,850USD£3,788GBP
- Clinical Trials
- July 2025
- 80 Pages
Global
From €1817EUR$2,000USD£1,562GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1136EUR$1,250USD£976GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2534EUR$2,789USD£2,178GBP
- Report
- May 2024
- 136 Pages
Global
From €2725EUR$2,999USD£2,343GBP
€3634EUR$3,999USD£3,124GBP
- Report
- May 2024
- 134 Pages
Global
From €2725EUR$2,999USD£2,343GBP
€3634EUR$3,999USD£3,124GBP

Alteplase is a thrombolytic drug used to treat cardiovascular diseases such as heart attack and stroke. It works by breaking down the clot that is blocking the blood flow to the heart or brain. Alteplase is administered intravenously and is the only thrombolytic drug approved by the US Food and Drug Administration (FDA). It is used in both acute and chronic cardiovascular diseases, and is often used in combination with other drugs. Alteplase is also used to treat pulmonary embolism, deep vein thrombosis, and peripheral arterial occlusion.
Alteplase is available in both generic and branded forms, and is manufactured by several pharmaceutical companies. Some of the companies in the market include Genentech, Boehringer Ingelheim, Pfizer, and Sanofi. Show Less Read more